Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS)

25 filings reported holding ANVS - Annovis Bio, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Annovis Bio, Inc. - Common Stock, par value $0.0001 per share (ANVS) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 752,202 shares of 19,607,843 outstanding shares and own 3.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (242,571 shares), BlackRock Inc. (94,246 shares), GEODE CAPITAL MANAGEMENT, LLC (51,650 shares), Merit Financial Group, LLC (42,900 shares), Wescott Financial Advisory Group, LLC (41,607 shares), Bank of New York Mellon Corp (34,223 shares), Redmond Asset Management, LLC (34,010 shares), Sterling Investment Advisors, Ltd. (33,374 shares), Modera Wealth Management, LLC (30,513 shares), and DIMENSIONAL FUND ADVISORS LP (25,251 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.